INTRODUCTION {#sec1-1}
============

*Thymelaea* is a genus (*Thymelaeaceae* family) comprising about 30 species of evergreen shrubs under the flowering plant family *Thymelaeaceae*. *Thymelaea microphylla* (TM) Coss. et Dur. is a medicinal species endemic to Algeria and very common in the arid and desert pastures.\[[@ref1]\] The leaves decoction is used in folk medicine to treat abscess, skin diseases, and abdominal pain and for anticancer, anti-inflammatory, and antidiabetic properties.\[[@ref2][@ref3]\] Another species of *Thymelaea* genus (*Thymelaea hirsuta* Endl.) is traditionally used for its several and well-documented antioxidant, anti-inflammatory, and anticancer properties.\[[@ref4][@ref5][@ref6][@ref7]\] On the contrary, only a few data dealing with the antibacterial and antioxidant activity of the extracts of TM,\[[@ref3][@ref8][@ref9]\] as well as on its chemical composition, are available.\[[@ref10][@ref11]\]

The present work aims to investigate, using *in vitro* cell-free chemical assays, *ex vivo* experiments, and cell culture-based tests, the antioxidant/free radical scavenger and anti-inflammatory properties of several extracts (obtained by water, ethanol, acetone, and hexane) from leaves and flowers of Algerian TM.

For this purpose, these extracts, characterized for their total content in flavonoids and flavonols, were tested in a battery of *in vitro* chemical assays differing in the mechanisms involved, the chemical environment used, and the stressor applied (Folin--Ciocalteu assay; bleaching of the s\[table 1\],1-diphenyl-2-picrylhydrazyl radical; 2,2\'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) radical scavenging activity; beta-carotene bleaching \[BCB\] test; scavenging activity against superoxide anion; prevention of heating-induced albumin denaturation). On the basis of the results of these experiments and also taking into account the evidence of cytotoxicity shown by these extracts on *in vitro* cultured peripheral blood mononuclear cells (PBMCs), the TM acetone extract (AcE) was investigated about its capability to inhibit cyclooxygenase (COX) activity, and consequently prostaglandin E~2~ (PGE~2~) and thromboxane B~2~ (TxB~2~) release, in whole blood, and to protect vessel endothelial cells against the damage induced by the proinflammatory cytokine tumor necrosis factor-α (TNF-α), in terms of cell viability, E-selectin expression, leukocyte adhesion, and cell-reduced glutathione (GSH) content.

MATERIALS AND METHODS {#sec1-2}
=====================

Chemicals {#sec2-1}
---------

Folin--Ciocalteu phenol reagent, analysis grade methanol, high-performance liquid chromatography (HPLC) grade methanol, fluorescein (FL) sodium nitrite, and hydrochloride acid were purchased from Carlo Erba (Milan, Italy). HPLC grade water, acetonitrile, aluminum chloride anhydrous and potassium peroxodisulfate were purchased from VWR International (Radnor, Pennsylvania, United States). All other reagents, if not specified, were purchased from Sigma-Aldrich (Milan, Italy).

Plant extract preparation {#sec2-2}
-------------------------

The plants of TM were collected in September 2011 from the region of M\'sila in East Algeria. The identification of the plant was based on the work of Quezel and Santa\[[@ref12]\] and validated by botanists in the Department of Botany and Ecology at the University of Setif (Algeria). The plant was air-dried in shade for 10 days at room temperature. Leaves and flowers were then separated from stems and used for extraction.

Four extracts (aqueous, ethanol, acetone, and hexane) were prepared from dried leaves and flowers of TM. Briefly, drug samples were powdered by a mill and to obtain the aqueous extract, 10 g of the sample was mixed with 100 ml of distilled water, left for 30 min at 70°C, and then left for 2 days under occasional stirring. To obtain ethanol, acetone, and hexane extracts, 10 g of the sample were mixed with 100 ml of each solvent for 48 under stirring and on the dark. Finally, the mixtures were filtered and evaporated to dryness under vacuum using a Rotavapor. The yields of the extractions, expressed as percentage, were 10.44%, 4.46%, 0.9%, and 1% for the aqueous, ethanolic, acetonic, and hexanic extracts, respectively. For the chemical and biochemical assays, the extracts were redissolved in the appropriate volume of dimethyl sulfoxide (DMSO).

Phytochemical screening {#sec2-3}
-----------------------

Extracts were screened for the presence of phytoconstituents (tannins, saponins, flavonoids, steroids, alkaloids, terpenoids, cardiac glycosides, and quinones) using the standard procedure described by Ganatra *et al*.\[[@ref13]\] and Doughari.\[[@ref14]\]

Total flavonoid and flavonol content {#sec2-4}
------------------------------------

The total content of flavonoids and flavonols in TM extracts was determined by the method described by Tomaino *et al*.\[[@ref15]\]

For the flavonoid content, aliquots (50 μl) of the solution containing the extracts to be tested (or catechin \[Cat\] used as standard) were diluted with distilled water to a final volume of 0.5 ml, and 30 μl of 5% NaNO~2~ was added. After 5 min, the mixture with 60 μl of 10% AlCl~3~ was added, consequently after 6 min, with 200 μl of 1 M NaOH and 210 μl of distilled water. Absorbance was recorded at 510 nm using a Shimadzu UV-1601 spectrophotometer.

For the total content of flavonols, aliquots (125 µl) of the solutions containing the extracts to be tested (or quercetin \[Que\] used as standard) were mixed with 125 µl of AlCl~3~ (2 mg/ml) and 750 µl of sodium acetate (50 mg/ml). The absorbance at 440 nm was detected after 2.5 h.

Total flavonoid and flavonol contents were expressed as µg of Cat equivalents (eq) and µg of Que eq per mg of dried extract, respectively. All determinations were carried out in duplicate and repeated at least 3 times. Results are expressed as means ± standard deviation (SD) from three experiments.

*In vitro* biochemical assays {#sec2-5}
-----------------------------

### Folin--Ciocalteu colorimetric method {#sec3-1}

The antioxidant capacity (expressed as total phenols content) of the extracts was determined using the Folin--Ciocalteu reagent.\[[@ref16]\] Fifty microliters of the solutions containing different concentrations of the extracts to be tested, or of the vehicle alone (DMSO), were added to 450 µl of deionized water, 500 µl of Folin--Ciocalteu reagent, and 500 µl of 10% aqueous sodium carbonate solution; samples were then maintained at room temperature for 1 h. Absorbance was measured at 750 nm (UV-Vis Spectrophotometer, Shimadzu, Japan) against the blank containing 50 µl of the same solvent used to dissolve the extracts. Total phenol content was expressed as µg of gallic acid eq per mg of extract, using calibration curve prepared with gallic acid standard solutions. Each determination was carried out in triplicate. Results are expressed as means ± SD from three experiments.

### 2,2-diphenyl-1-picrylhydrazyl test {#sec3-2}

The free radical-scavenging capacity of extracts was determined by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay,\[[@ref17]\] a method based on the reduction of the stable radical DPPH. The reagent mixture consisted of 1.5 ml of 100 mM DPPH in methanol, to which 37.5 µl of solutions containing various concentrations of the extracts to be tested, or of the vehicle alone (DMSO), were added; an equal volume of the solvent employed to dissolve the extracts was added to control tubes. After 20 min of incubation at room temperature, the absorbance was recorded at 517 nm in a UV-Vis spectrophotometer. Each determination was carried out in triplicate.

### 2,2\'-azinobis-(3-ethyl-benzothiazolin-6-sulfonic acid) assay {#sec3-3}

This method determines the capacity of the TM extracts to quench the stable 2,2\'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) radical (ABTS^·+^). In our experiments,\[[@ref18]\] the ABTS^·+^ radical cation was produced by the oxidation of 1.7 mM ABTS with potassium persulfate (4.3 mM final concentration) in water. The mixture was allowed to stand in the dark at room temperature for 12--16 h before use, and then the ABTS^·+^ solution was diluted with phosphate buffered saline (PBS) at pH 7.4 to give an absorbance of 0.7 ± 0.02 at 734 nm. One hundred microliters of a solution containing different concentrations of TM extracts to be tested or of the vehicle alone (DMSO) was added to 2 ml of the ABTS^·+^ solution, and the absorbance was recorded at 734 nm in a UV-Vis spectrophotometer after allowing the reaction to stand for 6 min in the dark at room temperature. Each determination was carried out in triplicate.

### Oxygen radical absorbance capacity assay {#sec3-4}

The oxygen radical absorbance capacity (ORAC) assay was performed as described by Dávalos *et al*.\[[@ref19]\] and adapted in our laboratory.\[[@ref20]\] This assay is based on the effect of peroxyl radicals generated from the thermal decomposition of 2,2\'-azobis (2-methylpropionamidine) dihydrochloride (AAPH) on the signal intensity from the fluorescent probe FL in the presence of an oxygen radical absorbing substance. The reaction was carried out in 75 mM phosphate buffer (pH 7.4), and the final reaction mixture was 2 ml. An aliquot of the solution containing different concentrations of TM extracts to be tested (200 μl), or the same volume of the vehicle alone (DMSO), and 1.2 ml of FL solution (70 nM, final concentration) was placed in a cuvette. The mixture was preincubated for 15 min at 37°C in the spectrofluorometer. Freshly prepared AAPH solution (600 μl; 12 mM, final concentration) was rapidly added. Fluorescence was recorded every minute for 80 min at 37°C; the fluorescence conditions were excitation at 485 nm and emission at 520 nm. A blank containing FL and AAPH but only the solvent employed to dissolve the extracts, and different calibration solutions using Trolox (1--7.5 μM, final concentration) as reference antioxidant, was also carried out in each assay. All the reaction mixtures were prepared in triplicate, and at least three independent assays were performed for each sample. The area under the curve (AUC) was calculated for each sample by integrating the relative fluorescence curve. The net AUC was calculated by subtracting the AUC of the blank. The final ORAC values were determined by linear regression equation of Trolox concentrations and expressed as mmol Trolox eq/g dried extract. Results are expressed as means ± SD from three experiments.

### Beta-carotene bleaching assay {#sec3-5}

The BCB potential of TM extracts was determined following the method of Martorana *et al*.\[[@ref21]\] To prepare a stock solution of a β-carotene-linoleic acid mixture, 1 mg of β-carotene was dissolved in 10 ml of chloroform (HPLC grade), and then 5 ml of this solution were added to 40 μl of linoleic acid and 400 μl of Tween 40. Chloroform was removed using a rotary evaporator at 40°C for 5 min, and then 100 ml of distilled water were slowly added to the residue to form an emulsion. Five milliliters of the emulsion was added to 200 μl of a solution containing the extracts to be studied at different concentrations; the same volume of the solvent alone (DMSO) was used in control samples. The absorbance was immediately measured (*t* = 0 min) at 470 nm against a blank, consisting of an emulsion without β-carotene. Then, the samples were placed in a water bath at 50°C, and the oxidation of the emulsion was monitored by measuring absorbance at 470 nm 120 min after the beginning of the reaction. The percentage of inhibition respect to the control was calculated as follows:

\% of inhibition = (\[A~t~ − C~t~\]/\[C~0~ − C~t~\])/100

where A~t~ and C~t~ are the absorbances measured for the sample to be tested and the control one, respectively, at *t* = 120 min, and *C*~0~ is the absorbance value for the control measured at *t* = 0 min. Each determination was carried out in triplicate.

### Scavenging activity against the superoxide anion (superoxide dismutase assay) {#sec3-6}

The scavenging capability against the superoxide anion of TM extracts was measured by the method described by Tomaino *et al*.\[[@ref15]\] and Tuttolomondo *et al*.\[[@ref16]\] with little modifications. The nonenzymatic system phenazine methosulfate/nicotinamide adenine dinucleotide (PMS/NADH) generates O~2~^−^, which reduces nitroblue tetrazolium (NBT) to a purple formazan. Twenty microliters of each extract solution, tested at different concentrations, or the vehicle alone was added to 1.5 ml of the reaction mixture containing 500 μl of NADH (73 μM), 500 μl of NBT (50 μM), and 500 μl of PMS (15 μM); all reagents were prepared in Tris-HCl (16 mM, pH 8). After incubation for 2 min at room temperature, the absorbance was measured at 560 nm to determine the concentration of formed formazan. Each determination was carried out in triplicate.

### Inhibition of heat-induced albumin denaturation {#sec3-7}

We measured the capability of TM extracts to inhibit heat-induced albumin denaturation.\[[@ref22]\] The reaction mixture consisted of 100 µL of solution of each extract to be tested, or the same volume of the vehicle alone (DMSO), 1.9 ml of phosphate buffer 0.2 M (pH 7.4) and 1 ml of bovine serum albumin solution (1%). The mixture was incubated at 37°C for 20 min and then heated to 51°C for other 20 min. After cooling, the turbidity of the samples was measured by reading the absorbance at 660 nm. Each determination was carried out in triplicate.

*Ex vivo* experiments {#sec2-6}
---------------------

### Release of prostaglandin E~2~ and thromboxane B~2~ in whole blood {#sec3-8}

To characterize the anti-inflammatory properties of the TM water and AcE, we used a human whole blood assay to assess its ability to act as *in vitro* selective inhibitors of COX-1 or COX-2 pathways, by decreasing release of TxB~2~ and PGE~2~, respectively.\[[@ref23][@ref24]\]

Peripheral blood samples were drawn from healthy volunteers who had taken no anti-inflammatory drug during the last 2 weeks before the study. Informed consent was obtained from each subject.

To evaluate changes in PGE~2~ release, 1 mL of peripheral blood aliquots containing 10 IU of sodium heparin was incubated in the presence of lipopolysaccharide (LPS; 10 μg/mL) for 24 h at 37°C. The contribution of platelet prostaglandin endoperoxide synthase-1 was suppressed by adding aspirin (10 μg/mL) at time 0. Then, plasma was separated by centrifugation (10 min at 1600 × *g*) and kept at − 30°C until assayed for the content of PGE~2~, which is an index of the COX activity of blood monocyte prostaglandin endoperoxide synthase-2.

To evaluate changes in TxB~2~ release, 1 mL of whole blood aliquots was immediately transferred into glass tubes and allowed to clot at 37°C for 1 h. Serum was separated by centrifugation (10 min at 1600 × *g*) and kept at − 30°C until assayed for TxB~2~, which is an index of endogenously formed thrombin-stimulated COX activity of platelet prostaglandin endoperoxide synthase-1. Plasma PGE~2~ and serum TxB~2~ were measured by enzyme immunoassay (using kits purchased from Cayman chemical, USA).

To evaluate the effects of the extract on PGE~2~ and TxB~2~ in whole blood, TM extracts were dissolved in DMSO and 2 μl of these solutions was put into test tubes to give a final concentration in whole blood ranging between 320 and 5 μg/mL. The experiments were then carried out as described above. As reference drugs, the nonsteroid anti-inflammatory drugs, indomethacin as non-selective COX inhibitor and nimesulide as selective COX-2 inhibitor, were used. Each determination was performed in triplicate; the results were expressed as percentage decrease with respect to control values and were reported as mean ± SD of three experiments.

*In vitro* experiments on cell systems {#sec2-7}
--------------------------------------

### Toxicity on peripheral blood mononuclear cells {#sec3-9}

PBMCs (pool of five donors) have been isolated from whole blood with Histopaque-1077 (Sigma-Aldrich), according to the manufacturer\'s instructions, suspended in RPMI-1640 and immediately used.\[[@ref25]\] One milliliter of PBMC suspension (1 × 10^6^ cells/mL) was exposed to TM extracts (dissolved in DMSO) and incubated at 37°C for 24 h. Cell cultures exposed only to the same volume of the vehicle (DMSO; 0.1% final concentration) were used as controls. Changes in viability of PBMCs exposed to plant extracts were evaluated using the trypan blue exclusion assay.\[[@ref26]\] Briefly, 10 μl of cell suspension was mixed with 30 μl of trypan blue isotonic solution (0.4% w/v) and loaded into a hemocytometer for both live and dead cell counting.

Protective effects on human umbilical vein endothelial cells exposed to tumor necrosis factor-α {#sec2-8}
-----------------------------------------------------------------------------------------------

### Cell cultures {#sec3-10}

Human umbilical vein endothelial cells (HUVECs) were isolated from freshly obtained human umbilical cords by collagenase digestion of the interior of the umbilical vein and were cultured in medium 199, supplemented with 20% fetal bovine serum, 1% L-glutamine, 20 mM HEPES, 100 units/mL penicillin/streptomycin, 50 mg/mL endothelial cell growth factor, and 10 μg/mL heparin, in gelatin-pretreated flasks. Cells were maintained in a humidified atmosphere containing 5% CO~2~ in an incubator at 37°C. Cells used in this study were from the second to fourth passage. The final concentration of DMSO in the culture medium during different treatments was \<0.1% (v/v). The subconfluent cells were treated for 24 h in serum-free medium with various doses of TM AcE (20--40 μg/ml) whereas control cells were treated with 0.1% DMSO only. After this incubation time, cells were washed with PBS under sterile conditions and then incubated for 2 h with serum-free medium containing various doses of recombinant human TNF-α (20 ng/mL) as previously reported (Speciale *et al*. 2010, 2013). Control cells were not exposed to TNF-α. At the end of the exposure time, cells were immediately processed and/or preserved at − 80°C until analysis as expected for each test. The cytotoxic effect of TNF-α on HUVECs pretreated or not with TM AcE was evaluated using trypan blue exclusion assay.

Leukocyte adhesion {#sec2-9}
------------------

Mononuclear cells have been isolated from human whole blood with Histopaque-1077, following the procedure recommended by the manufacturer. Briefly, heparinized venous blood from healthy donors was centrifuged over Histopaque-1077; the mononuclear cell layer was collected, washed twice with DPBS, suspended in medium 199, and immediately used. Two flasks with subconfluent HUVECs were treated with various doses of AcE (20--40 μg/ml) and were incubated for 24 h at 37°C in a humid 5% CO~2~ atmosphere incubator. Two controls were treated with the medium containing only 0.1% DMSO. After this pretreatment, cells were washed with DPBS under sterile conditions and then co-cultured with leukocytes (3 × 10^6^ leukocytes/flask) and TNF-α 20 ng/mL for 2 h at 37°C with gentle shaking. Cells not exposed to TNF-α were used as controls. After this incubation time, medium was removed and cells were washed with DPBS. Co-cultures were visualized under an inverted microscope and photographed using a digital camera. Four areas for each flask were selected and used to count the number of adherent leukocytes. Increase in leukocyte adhesion upon stimulation of HUVECs with TNF-α was calculated in relation to the basal adhesion of leukocytes to unstimulated HUVECs, which was set to 1.

Quantitative reverse transcription-polymerase chain reaction {#sec2-10}
------------------------------------------------------------

Total cellular RNA was isolated according to the TRIzol protocol as previously described.\[[@ref27][@ref28]\] The quality of the RNA was tested in 1% formaldehyde-agarose gel stained with ethidium bromide (EtBr) and spectrophotometrically quantified. After reverse transcription with oligo(dT)~15~ primers polymerase chain reaction (PCR) was performed for identification of E-selectin mRNA levels. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as housekeeping gene for normalization. Gene expression was assessed by real-time PCR (Applied Biosystem 7300 Real-Time PCR System, Monza, Italy) coupled with the Sybr green JumpStart Taq ReadyMix kit. The specific primers set for the target genes were as follows: GAPDH, forward, 5\'-GGC TCT CCA GAA CAT CAT CCC TGC-3\', reverse, 5\'-GGG TGT CGC TGT TGA AGT CAG AGG-3\'; E-selectin, forward, 5\'-CTG CCA AGT GGT AAA ATG TTC AAG-3\', reverse, 5\'-TTG GAC TCA GTG GGA GCT TCA-3\'. Cycling conditions were 40 cycles of 94°C denaturation (15 s), 60°C annealing and extension (1 min). A final dissociation stage was run to generate a melting curve for verification of amplification product specificity. Each sample was assayed at least 3 times from the same RNA. Data were collected and processed with SDS 1.3.1 software (Applied Biosystems, Monza, Italy) and given as threshold cycle (Ct). The fold increase compared with the control cells not treated and not exposed to TNF-α mRNA expression was determined using the 2^−ΔΔCt^ method. Primer efficiencies for the test gene were comparable to those for GAPDH (reference gene).

Cell content of glutathione {#sec2-11}
---------------------------

Intracellular GSH concentration was detected by HPLC (Shimadzu, Milan, Italy) coupled with a fluorescent detector (Hewlett-Packard 1046A) as described elsewhere.\[[@ref28][@ref29]\] Quantization was performed by comparing derivative peak area to known standards. Results were normalized with protein content determined with the Bradford assay.

Statistical analysis {#sec2-12}
--------------------

The Litchfield and Wilcoxon test was used to express the results as mean scavenging concentrations (SC~50~ for DPPH and ABTS assays) or mean inhibition concentrations (IC~50~ for superoxide dismutase \[SOD\] assay, BCP assay, protein denaturation inhibition, PGE~2~, and TxB~2~ release inhibition) and 95% confidence limits (95% CL). Statistics were carried out using PHARM/PCS Version 4 (MCS Consulting) software.

The results obtained in experiments on cell cultures are expressed as means ± SD from three experiments and were statistically analyzed by the ANOVA test, followed by Tukey\'s HSD, using the statistical software ezANOVA (<http://www.sph.sc.edu/comd/rorden/ezanova/home.html>). Differences in groups and treatments were considered statistically significant for *P* \< 0.05.

RESULTS AND DISCUSSION {#sec1-3}
======================

Phytochemical profile and antioxidant properties {#sec2-13}
------------------------------------------------

The phytochemical characterization evidenced the presence of tannins in all extracts; flavonoids and flavonols in all extracts, especially in the acetone extract \[[Table 1](#T1){ref-type="table"}\]; saponins only in the aqueous extract; steroids in ethanolic and acetonic extracts; terpenoids in all the extracts except the ethanolic one; cardiac glycosides in hexanic and acetonic extracts; quinones in aqueous and acetonic extracts. No presence of alkaloids was observed in all the extracts examined. Furthermore, preliminary studies, carried out by means of HPLC with UV/VIS detection, confirmed the presence, only in the aqueous extract, of discrete amounts (expressed as mean ± relative SD of three different analyses) of phenolic acids (in particular: gallic acid 2.30 ± 1.79 µg/mg extract, ferulic acid 1.71 ± 3.08 µg/mg extract, p-coumaric acid 2.32 ± 0.56 µg/mg extract, caffeic acid 2.812 ± 0.346 µg/mg extract), as well as the presence of luteolin and kaempferol in acetone and ethanol extracts (luteolin: 4.12 ± 1.48 and 6.61 ± 1.48 µg/mg extract, respectively; kaempferol: 1.96 ± 4.65 and 2.19 ± 4.73, respectively). These data are in agreement with those previously reported by other authors\[[@ref10][@ref11]\] who evidenced the presence of flavonoids and phenolic acids together with monoterpene glucosides, phenylpropanoid glucosides, ionol glucosides, and lignans in hydroalcoholic extracts from TM aerial parts.

###### 

Content of total flavonoids and flavonols, and of gallic acid equivalents (as calculated in the Folin assay) determined in different TM extracts. Results are expressed as mean±S.D. of three determinations

![](PM-12-203-g002)

Since the antioxidant activity measured by an individual assay can reflect only the chemical reactivity under the specific conditions applied in that assay, we carried out a battery of four different simple redox-based assays differing in the mechanisms involved and the chemical environment used: Folin--Ciocalteu assay, bleaching of the stable radical DPPH, ABTS assay, ORAC assay, BCB test.

Among these assays, ORAC is a hydrogen atom transfer (HAT) reaction based assay while total phenols assay by Folin--Ciocalteu reagent is a single electron transfer (ET) reaction based assay; furthermore, we used the ABTS and DPPH assays which are usually classified as ET reactions although the two indicator radicals employed may be neutralized either by direct reduction via ETs or by radical quenching via H atom transfer. However, ORAC- and Folin--Ciocalteu-based assays are not suitable for measuring lipid-soluble antioxidants; conversely, the strong point of ABTS is that it can be applied for both water- and lipid-soluble antioxidants while DPPH is soluble only in organic solvents. Unlike all the other assays, the BCB test is performed in a heterogeneous system; in fact, the presence of two phases, one hydrophilic and one hydrophobic, might limit the antioxidant power of compounds unable to reach the organic phase (where lipoperoxidation occurs) and/or to interact with lipid micelles/biomembranes. The BCB test is a proton-transfer based assay, given that the scavenging of the lipo-peroxyl radicals by an antioxidant is thought to be a proton-transfer based reaction, and thus it allows us to evaluate the capacity of a compound to act as a chain-breaking antioxidant in the process of lipid peroxidation. The pro-oxidant agent used in this assay is heating, the same that is used in the albumin denaturation assay. The heat-induced albumin denaturation, as well as the superoxide anion scavenging assay, was carried out to investigate the anti-inflammatory capability of the TM extracts under the study. In fact, the superoxide anion O~2~^•-^ is the major reactive oxygen species and plays a pivotal role in inflammation; the enzyme SOD neutralizes O~2~^•-^ by transforming it into hydrogen peroxide, thereby preventing the formation of highly aggressive compounds such as peroxynitrite and hydroxyl radical. On the other hand, protein denaturation (a process in which proteins lose their tertiary structure and secondary structure, and consequently their function, by application of external stressors or compounds, such as strong acids or bases, concentrated inorganic salts, organic solvents or heat) is a well-documented cause of inflammatory diseases.\[[@ref30]\]

The full results are summarized in [Table 1](#T1){ref-type="table"} and in [Table 2](#T2){ref-type="table"}. All tested extracts showed a good antioxidant/free radical scavenger activity. In the ET-based assays, the potency order was water \> acetone \> ethanol \>\> hexane while in the HAT-based assay (ORAC), the potency order was water \> ethanol \> acetone \>\> hexane. These findings demonstrate that all the extracts of TM have a similar chemical profile as concerns the presence of antioxidants/radical scavengers acting by both HAT and ET. On the other hand, the acetone and hexane extracts are very likely richer, in comparison with the water and ethanol extracts, of antioxidants able to rich the lipophilic phase; in fact, in the BCB assay, the potency order was acetone \> hexane \> ethanol \>\> water (IC~50~ values ranging between 0.16 and 1.29 mg/ml). Similarly, in the protein denaturation assay, IC~50~ values ranged respectively between 1.807 and 11.54 mg/ml and the potency order was acetone \> hexane \> ethanol \>\> water. Interestingly, further, in the SOD mimetic assay (where IC~50~ values ranged respectively between 0.147 and 1.115 mg/ml), the AcE appeared to be endowed with the highest activity (acetone \> hexane \> ethanol \>\> water) \[[Table 2](#T2){ref-type="table"}\].

###### 

Antioxidant activity/free radical scavenger of *T. microphylla* extracts measured by means of different *in vitro* tests. Results are expressed as: mean±SD of 3 experiments for ORAC values; 50% scavenging concentration (SC~50~) and 95% confidence limits (CL) in the DPPH and ABTS assays; 50% mean inhibition concentration (IC~50~) and 95% confidence limits (CL) in the SOD, protein denaturation and BCB assay. §TE: Trolox equivalents

![](PM-12-203-g003)

Taking into account all these findings, the TM AcE is that showing the best anti-inflammatory activity together with good antioxidant/radical scavenger properties while the TM water extract has the best antioxidant activity but seems lacking anti-inflammatory properties.

Citotoxicity on blood mononuclear cells {#sec2-14}
---------------------------------------

To evaluate the cytotoxic effects of TM extracts, we used human fresh-isolated PBMCs because these cells can be easily collected and cultured and the results obtained may be of great significance as biomarkers of toxic responses to chemicals.\[[@ref25]\] Cell viability of PBMCs exposed to different doses of TM extract (20, 40, 80 μg/ml) was evaluated by the trypan blue exclusion assay. As reported in [Figure 1](#F2){ref-type="fig"}, after 24 h of cell exposure to TM extracts, only the TM ethanolic extract, at all tested doses, and also the water extract, at the highest dose tested, induced a significant cell death in a dose-dependent manner. On the contrary, the other two TM extracts did not affect cell viability.

![Cell viability, evaluated in the trypan blue assay, of human blood mononuclear cells exposed for 24 h to three doses of *Thymelaea microphylla* extracts. Cultures treated with vehicle alone were used as controls. Data represent percentage of viable cells (mean percentage) calculated from the number of viable cells in treated samples versus control/that was considered as 100%). Each point represents mean ± standard deviation of three experiments. \**P* \< 0.05 versus vehicle treated cells](PM-12-203-g004){#F2}

Anti-inflammatory activity of extracts {#sec2-15}
--------------------------------------

The two COX isoforms COX-1 and COX-2 have an important role in inflammation and tumorigenesis. We assessed the ability of the TM AcE and water extract to act as selective inhibitors of COX pathways, by decreasing release of TxB~2~ and PGE~2~ in whole blood. In fact, constitutive COX-1 and inducible COX-2 convert arachidonic acid released from the cell membrane in response to stimulation to PGE~2~, which is then further metabolized by other enzymes to various prostaglandins, prostacyclins, and thromboxanes.

The TM AcE showed a good capability to inhibit release of both TxB~2~ and PGE~2~. However, also, at the highest dose tested (320 μg/ml), the inhibition in TxB~2~ release was not more than 50%. Conversely, it appeared more strongly inhibit PGE~2~ allowing us to calculate an IC~50~ 15.12 μg/ml (95% CL: 12.84--17.79 µg/ml). Thus, the TM AcE could be able to inhibit the COX pathways. However, unlike tests performed on purified enzymes that only show a purely drug--enzyme interaction, it should be considered that other interactions can exist in an *ex vivo* test where the inhibitory potency is measured at a cellular level. In particular, the rate of PGE~2~ production is related to COX-2 expression elicited by LPS. Several natural drugs are able to modulate cell signaling pathways and gene expression; thus, the effect of TM AcE could be due, partially at least, to a downregulation of COX-2 expression.

Conversely, the TM water extracts appeared unable, under these experimental conditions, to inhibit TxB~2~ release at all dose tested and showed only a weak capability to inhibit PGE~2~ release, being the IC~50~ value 348.45 µg/ml (95% CL 262.96--562.16 µg/ml) \[[Figure 2](#F3){ref-type="fig"}\].

![Effect of *Thymelaea microphylla* acetone extract on release of (a) thromboxane B2 (in comparison with that of indomethacin, Indo) and of (b) prostaglandin E2 (in comparison with that of nimesulide, NIM) in human whole blood. Data are expressed as mean ± standard deviation of three independent experiments](PM-12-203-g005){#F3}

Protective effect on tumor necrosis factor-α-induced endothelial dysfunction {#sec2-16}
----------------------------------------------------------------------------

Since the TM AcE was the only extract showing good chemical profile, significant antioxidant properties, and excellent anti-inflammatory and COX-inhibitory activity, together with lack of toxicity on normal human blood cells, only these TM extracts were tested about its protective effect on TNF-α-induced endothelial dysfunction.

In fact, oxidative stress and inflammation are considered among the prominent pathways of vascular endothelial dysfunction in many pathophysiological conditions. The proinflammatory cytokine TNF-α is often present in chronic inflammatory diseases, exerting a prominent effect on the expression of proinflammatory genes in endothelial cells. This effect takes place predominantly through activation of intracellular signaling pathways involving NF-κB. In endothelial cells, NF-κB is involved in the regulation of the expression of several genes, including those encoding E-selectin and COX-2. Many studies have demonstrated that the increased adhesion of circulating monocytes to the injured endothelial layer is a critical early event in the development of atherogenesis. In fact, endothelial cells recruit monocytes by selectively expressing various cell surface adhesion molecules such as E-selectin. Proinflammatory cytokines, such as TNF-α, can induce, through its ability to promote intracellular ROS formation and activation of the redox-sensitive transcription factor NF-κB, the expression and release of chemotactic factors and additional cytokines that can each further contribute to inflammation.

Hence, in this study, we studied the capability of TM AcE to alter the TNF-α-changes on HUVECs which are a model system widely used to identify the effects of and targets for deleterious vascular risk factors. At this aim, cells were pretreated with the extract (20--40 μg/ml) and then exposed for 2 h to TNF-α 20 ng/mL.

Our results indicate a clear cytotoxic effect of TNF-α. Cell pretreatment with TM AcE showed a dose-dependent protective effect against TNF-α-induced cell death. Furthermore, TM AcE alone was unable to affect cell viability at the tested doses \[[Figure 3](#F4){ref-type="fig"}\].

![Cell viability in human umbilical vein endothelial cells pretreated with *Thymelaea microphylla* acetone extract (20--40 μg/ml) for 24 h and then exposed for 2 h to tumor necrosis factor-α (20 ng/ml). Cultures treated with the vehicle alone (dimethyl sulfoxide 0.1%) were used as controls. Data represent percentage of viable cells (mean percentage) calculated from the number of viable cells in treated samples versus control untreated and unexposed. \**P* \< 0.05 versus respective tumor necrosis factor-α 0 ng/ml; §*P* \< 0.05 versus vehicle exposed to tumor necrosis factor-α 20 ng/ml](PM-12-203-g006){#F4}

Real-time PCR was used to evaluate E-selectin gene expression in endothelial cells as representative genes involved in cell adhesion. According to the data reported in the literature, cell exposure to TNF-α significantly induced the surface expression of E-selectin \[[Figure 4](#F5){ref-type="fig"}\]. TNF-α-induced upregulation of RNA expression of this adhesion molecule was significantly suppressed by pretreatment with TM AcE \[[Figure 4](#F5){ref-type="fig"}\]. TM AcE *per se*, without any kind of stimulus, had no effects on the basal expression of this gene.

![Effect of *Thymelaea microphylla* acetone extract on tumor necrosis factor-α induced mRNA expression of the adhesion molecule E-selectin, in human umbilical vein endothelial cells. Cells were pretreated with *Thymelaea microphylla* extract (20--40 μg/ml) for 24 h and then exposed for 2 h to tumor necrosis factor-α (20 ng/ml). Cultures treated with the vehicle alone (dimethyl sulfoxide 0.1%) were used as controls. Values are expressed as 2^−ΔΔCt^ normalized to control and reported as mean ± standard deviation of three experiments. \**P* \< 0.05 versus respective tumor necrosis factor-α 0 ng/ml; §*P* \< 0.05 versus vehicle exposed to tumor necrosis factor-α 20 ng/ml](PM-12-203-g007){#F5}

Adhesion molecules are responsible for leukocyte adhesion to vascular endothelium, so promoting their migration into subendothelial space, an early event in atherogenesis. To confirm the inhibitory activity of TM AcE on endothelial activation induced by TNF-α, we investigated isolated leukocytes co-cultured with HUVECs. [Figure 5](#F6){ref-type="fig"} shows that the number of leukocytes adhered to the endothelial cells exposed to TNF-α was higher than that observed in controls, but it appeared to be reduced by pretreatment with TM AcE. These results confirm the inhibitory activity of TM AcE on TNF-α-induced endothelial activation.

![Leukocyte adhesion to human umbilical vein endothelial cells pretreated with *Thymelaea microphylla* acetone extract (20--40 μg/ml) for 24 h and then exposed to tumor necrosis factor-α (20 ng/ml) for 2 h. A flask containing the co-culture and not exposed to tumor necrosis factor-α was used as control. Increase in leukocyte adhesion upon stimulation of human umbilical vein endothelial cells with tumor necrosis factor-α was calculated in relation to the basal adhesion of leukocytes to nonstimulated human umbilical vein endothelial cells (that was set to 1). Data are reported as mean ± standard deviation of three experiments. \**P* \< 0.05 versus respective tumor necrosis factor-α 0 ng/ml; §*P* \< 0.05 versus vehicle exposed to tumor necrosis factor-α 20 ng/ml](PM-12-203-g008){#F6}

To further investigate the protective effect of TM AcE against cytotoxic effects of TNF-α on HUVECs, we measured intracellular content of GSH. In fact, cellular thiol redox status is critical for a variety of biological process including transcriptional activation of various genes and regulation of cell proliferation, inflammation, and apoptosis. Thiols, particularly GSH, are also critical for cellular antioxidant defenses, including protecting the cells from oxidant injury and inflammation. In our present experiments, we found that GSH levels were significantly decreased in HUVECs exposed to TNF-α. As shown in [Table 3](#T3){ref-type="table"}, the pretreatment with the TM AcE was able to prevent, in a concentration-dependent way, the depletion in GSH cell content following exposure to TNF-α.

###### 

Changes in intracellular GSH levels in HUVECs pretreated for 24 h with *T. microphylla* acetone extract (20-40 μg/ml) and then for 2 h with TNF-α (20 μg/ml). Cultures treated with the vehicle alone (DMSO 0.1%) were used as controls. Data are expressed as mean±SD of the three independent experiments. °*P*\<0.05 vs respective TNF-α 0 ng/ml; \**P*\<0.05 vs vehicle exposed to TNF-α 20 ng/ml

![](PM-12-203-g009)

These findings contribute to confirm the hypothesis that several plant-derived polyphenols can suppress TNF-α activated inflammatory pathways.\[[@ref31]\] In particular, both luteolin and kaempferol, two flavonoids recovered in this drug, have been previously demonstrated to protect endothelial cells against cytokine-induced proinflammatory status.\[[@ref32][@ref33]\]

CONCLUSIONS {#sec1-4}
===========

This is the first time that leaves and flowers from TM are identified as a good source of bioactive compounds possessing significant antioxidant and anti-inflammatory properties, potentially effective in prevention and treatment of pathological conditions in which oxidative stress and inflammation play a significant role. In fact, in our experiments, TM appears able to decrease TxB~2~ and PGE~2~ release, very likely by an inhibition of COX activity, and further experiments could demonstrate a possible inhibitory effect of TM extracts selectively on the COX~1~ and COX~2~ pathways. Furthermore, due very likely to the mentioned bioproperties, the TM AcE is able to protect against endothelial dysfunction, which is an early event in development of atherosclerosis and vascular diseases. Further studies are warranted to better understand both the chemical composition of this drug and the cellular mechanisms involved in its pharmacological activity.
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